Home › Therapeutic areas › Respiratory › Progressive Pulmonary Fibrosis

Progressive Pulmonary Fibrosis (2 companies)

Companies with an active program in Progressive Pulmonary Fibrosis.

Ticker	Company	Therapeutic areas	Programs	Lead stage	Mkt cap	Programs
INSM	Insmed	CardiovascularImmunology+3 Rare	2	Approved	$25.1B	15
LQDA	Liquidia	CardiovascularImmunology+1 Rare	1	Approved	$3.97B	9